Weighted Average Number of Shares Outstanding, Basic of Roivant Sciences Ltd. from 30 Jun 2021 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Roivant Sciences Ltd. quarterly and annual Weighted Average Number of Shares Outstanding, Basic in shares history and change rate from 30 Jun 2021 to 31 Dec 2025.
  • Roivant Sciences Ltd. Weighted Average Number of Shares Outstanding, Basic for the quarter ending 31 Dec 2025 was 696,859,682, a 3.6% decline year-over-year.
  • Roivant Sciences Ltd. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 725,395,624, a 7.4% decline from 2023.
  • Roivant Sciences Ltd. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 783,248,906, a 9.9% increase from 2022.
  • Roivant Sciences Ltd. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 712,791,115, a 6.4% increase from 2021.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

Roivant Sciences Ltd. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 696,859,682 -25,856,486 -3.6% 01 Oct 2025 31 Dec 2025 10-Q 06 Feb 2026 2025 Q3
Q3 2025 680,947,866 -54,522,930 -7.4% 01 Jul 2025 30 Sep 2025 10-Q 10 Nov 2025 2025 Q2
Q2 2025 680,286,922 -55,529,614 -7.5% 01 Apr 2025 30 Jun 2025 10-Q 11 Aug 2025 2025 Q1
Q1 2025 725,395,624 -57,853,282 -7.4% 01 Jan 2025 31 Mar 2025 10-K 29 May 2025 2024 FY
Q4 2024 722,716,168 -77,871,548 -9.7% 01 Oct 2024 31 Dec 2024 10-Q 06 Feb 2026 2025 Q3
Q3 2024 735,470,796 -34,757,053 -4.5% 01 Jul 2024 30 Sep 2024 10-Q 10 Nov 2025 2025 Q2
Q2 2024 735,816,536 -23,457,014 -3.1% 01 Apr 2024 30 Jun 2024 10-Q 11 Aug 2025 2025 Q1
Q1 2024 783,248,906 +70,457,791 +9.9% 01 Jan 2024 31 Mar 2024 10-K 29 May 2025 2024 FY
Q4 2023 800,587,716 +87,268,317 +12% 01 Oct 2023 31 Dec 2023 10-Q 10 Feb 2025 2024 Q3
Q3 2023 770,227,849 +70,339,788 +10% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024 2024 Q2
Q2 2023 759,273,550 +63,394,691 +9.1% 01 Apr 2023 30 Jun 2023 10-Q 09 Aug 2024 2024 Q1
Q1 2023 712,791,115 +43,037,657 +6.4% 01 Jan 2023 31 Mar 2023 10-K 29 May 2025 2024 FY
Q4 2022 713,319,399 +26,729,921 +3.9% 01 Oct 2022 31 Dec 2022 10-Q 13 Feb 2024 2023 Q3
Q3 2022 699,888,061 +49,662,297 +7.6% 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023 2023 Q2
Q2 2022 695,878,859 +46,022,656 +7.1% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023 2023 Q1
Q1 2022 669,753,458 01 Jan 2022 31 Mar 2022 10-K 28 Jun 2023 2023 FY
Q4 2021 686,589,478 01 Oct 2021 31 Dec 2021 10-Q 13 Feb 2023 2022 Q3
Q3 2021 650,225,764 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022 2022 Q2
Q2 2021 649,856,203 01 Apr 2021 30 Jun 2021 10-Q 15 Aug 2022 2022 Q1

Roivant Sciences Ltd. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 725,395,624 -57,853,282 -7.4% 01 Apr 2024 31 Mar 2025 10-K 29 May 2025 2024 FY
2023 783,248,906 +70,457,791 +9.9% 01 Apr 2023 31 Mar 2024 10-K 29 May 2025 2024 FY
2022 712,791,115 +43,037,657 +6.4% 01 Apr 2022 31 Mar 2023 10-K 29 May 2025 2024 FY
2021 669,753,458 01 Apr 2021 31 Mar 2022 10-K 28 Jun 2023 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.